world
NeuroScientific specialist hire sets stage for major Crohn’s trial
The Sydney Morning Herald
October 1, 2026
via The Sydney Morning HeraldYou're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's News
NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.